Drug Shortage Report for CEFAZOLIN FOR INJECTION

Last updated on 2018-10-20 History
Report ID 62580
Drug Identification Number 02437112
Brand name CEFAZOLIN FOR INJECTION
Common or Proper name CEFAZOLIN FOR INJECTION
Company Name HIKMA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) CEFAZOLIN
Strength(s) 1G
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS
Packaging size PACK OF 25
ATC code J01DB
ATC description OTHER BETA-LACTAM ANTIBACTERIALS
Reason for shortage Delay in shipping of the drug.
Anticipated start date
Actual start date 2018-09-24
Estimated end date 2018-10-19
Actual end date 2018-10-19
Shortage status Resolved
Updated date 2018-10-20
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 5995 AVEBURY ROAD, SUITE 804
MISSISSAUGA, ONTARIO
CANADA L5R 3P9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2018-09-28 English Compare
v2 2018-09-28 French Compare
v3 2018-10-19 English Compare
v4 2018-10-19 French Compare
v5 2018-10-20 English Compare

Showing 1 to 5 of 5